Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300086
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,694
Award facts
- Contract value 100% obligated
- $6,693.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc., a Maryland-based subsidiary of the global Lonza Group and established supplier of biological materials and scientific research equipment, received a Blanket Purchase Agreement (BPA) call award valued at $6,693.84 from the Department of Health and Human Services Office of Logistics and Acquisition Operations. The contract, awarded on May 4, 2017, with a completion date of December 31, 2017, falls under the Drugs and Biologicals category and utilizes firm fixed pricing with no set-aside designation. The work will be performed at Lonza Walkersville's facility in Walkersville, Maryland. This BPA call represents a task order against the company's larger $10 million single-award BPA with HHS, valid through December 31, 2025, which provides streamlined access to biological materials, blood products, media products, laboratory supplies, and medical and scientific equipment for multiple National Institutes of Health institutes and research centers.
The procurement supports critical biomedical and life sciences research infrastructure across federal agencies, including the National Cancer Institute, National Heart Lung and Blood Institute, and National Institute of Allergy and Infectious Diseases. Lonza Walkersville has demonstrated consistent capability in delivering specialized research products such as cell culture media, cell lines, transfection devices, and advanced scientific instrumentation to support research initiatives in cancer studies, infectious diseases, regenerative medicine, and cellular engineering. The modest contract value reflects a single task order within the broader BPA framework, consistent with the company's historical pattern of providing targeted scientific materials and equipment to support ongoing federal research operations.
Quick answers
Who was awarded contract HHSN26300086?
HHSN26300086 was awarded to Lonza Walkersville, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on May 4, 2017.
How much is contract HHSN26300086 worth?
The government has obligated $6,694 on HHSN26300086.
Is contract HHSN26300086 an order under another contract?
Yes. HHSN26300086 is a BPA call under HHSN263201600052B, a blanket purchase agreement.
Was contract HHSN26300086 competed?
The extent of competition for HHSN26300086 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award